Dr. Roger Stupp, MD
Chair
Dr. Roger Stupp is Chief of Neuro-Oncology in the Department of Neurology and Neurological Surgery at Northwestern University Feinberg School of Medicine and Co-Director of the Northwestern Medicine Lou and Jean Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University at Northwestern Memorial Hospital in Chicago, Illinois. As Associate Director of Strategic Initiatives, he is instrumental in the development and oversight of Lurie Cancer Center’s strategic scientific initiatives applying advanced technologies and collaborative approaches to accelerate and widen the scope of clinical research. Dr. Stupp’s clinical interests include the multimodality management of primary and secondary brain tumors, head and neck tumors, and lung cancers, as well as new drug development and the association of chemotherapy and radiation therapy. Dr. Stupp’s work has repeatedly led to the establishment of a new standard of care for newly diagnosed glioblastoma, namely he was instrumental in developing and establishing the combination of temozolomide and radiotherapy, and more recently, for the clinical development of Tumor Treating Fields in brain tumors.
Dr. Michael Lim
Dr. Michael Lim is the Chairman of the Department of Neurosurgery at Stanford University, Stanford California. He is a board-certified neurosurgeon specializing in brain tumors and trigeminal neuralgia. Dr. Michael Lim is a global leader in cancer immunotherapy with a strong focus on neurological tumors. Dr. Lim has extensive clinical experience in treating brain tumors by deploying the most advanced surgical techniques. In addition to running a successful laboratory, Dr. Lim has experience in developing novel therapies and advancing these pharmaceuticals into the clinic. Dr. Lim has published more than 200 scientific articles on neuropathic pain, glioblastoma multiforme, and gliomas. Such publications have appeared in high-profile journals such as Science Translational Medicine, Clinical Cancer Research, Lancet Oncology, and Nature Immunology.
Dr. Monika Hegi, PhD
Dr. Monika Hegi is the Head of the Laboratory of Brain Tumour Biology and Genetics at Centre Hospitalier Universitaire Vaudois (CHUV) and Professor at the University of Lausanne, Switzerland. Dr Monika Hegi is the recipient of numerous awards including the Victor Levin for Neuro-Oncology research. She has authored more than 100 scientific publications in the most prestigious scientific journals. She specializes in the identification of predictive factors in therapeutic response and in the exploration of novel druggable targets. Dr. Hegi’s research focuses on glioma epigenetics, molecular mechanisms of gliomas, and translational research.
